Three Healthcare Stocks Offer Yields Above 6%, But Investors Face Mixed Outlooks

As interest rates remain elevated and bond yields compete for investor attention, a select group of healthcare stocks continue to attract income-focused investors with dividend yields significantly above market averages. Three names stand out for their outsized payouts: Perrigo Company at 9.6% yield, Healthpeak Properties at 7.1%, and Medical Properties Trust at 6.8%. However, beneath these attractive headline numbers lies a more complex picture of sector dynamics, company-specific challenges, and divergent risk profiles that warrant careful examination.

While the healthcare sector remains a cornerstone of dividend investing due to the essential nature of its services, these three stocks exemplify why high yields can sometimes signal underlying business pressures rather than straightforward bargains. Each company faces distinct headwinds that explain their elevated payout ratios, ranging from margin compression and growth stagnation to asset quality concerns and debt maturity walls. Understanding the drivers behind these yields is crucial for investors seeking sustainable income rather than yield-chasing traps.

Key Details: Understanding the Three High-Yield Leaders

Perrigo Company currently sports the highest yield of the trio at 9.6%, representing a 23-year streak of consecutive dividend payments. The company's impressive dividend history underscores a long-term commitment to shareholder returns, yet recent performance raises questions about sustainability. Perrigo faces a troubling combination of growth slowdown and profitability pressure that threatens to squeeze the dividend cushion that has accumulated over more than two decades.

Healthpeak Properties, the healthcare real estate investment trust (REIT), offers a 7.1% yield with what management views as a compelling strategic inflection point. The company's potential upside stems from a planned spinoff of its Janus Living portfolio, which could unlock value for shareholders through separate capital structures, management teams, and strategic flexibility. This corporate action adds a potential catalyst dimension absent from the pure dividend yields of its peers.

Medical Properties Trust rounds out the trio with a 6.8% yield, though this represents a stabilization following major dividend cuts triggered by tenant bankruptcies. The company has weathered significant operational challenges, most notably related to healthcare facility operator distress, which forced it to slash distributions. Despite achieving some stabilization, ongoing debt maturities loom as a near-term concern that could pressure both the balance sheet and dividend sustainability.

Key metrics across the three companies:

• Perrigo: 9.6% yield | 23-year dividend streak | Growth and profitability headwinds
• Healthpeak Properties: 7.1% yield | Janus Living spinoff potential | REIT structure
• Medical Properties Trust: 6.8% yield | Post-dividend cut stabilization | Debt maturity concerns

Market Context: Healthcare Dividends in a Shifting Landscape

The healthcare sector's evolution has created a bifurcated dividend landscape. Traditional pharmaceutical and medical device manufacturers typically offer moderate, sustainable yields backed by strong cash flows. In contrast, healthcare REITs and specialized companies like Perrigo face greater cyclicality and operational pressures that can lead to either unsustainable high yields or eventual dividend cuts.

The broader healthcare sector has undergone significant structural changes in recent years. Medicare reimbursement pressures, the consolidation of hospital systems, and the rise of specialized operators have created winners and losers. Companies exposed to vulnerable tenants or facing generic drug pressures—like Perrigo, which derives significant revenue from generic pharmaceuticals—face margin compression despite stable demand for their core products.

Healthcare REITs, including Healthpeak Properties and Medical Properties Trust, have grappled with the aftermath of operator bankruptcies and financial distress. The industry witnessed the spectacular collapse of NexPoint Residential Trust's healthcare portfolio exposure and multiple bankruptcies among healthcare facility operators, making tenant quality and lease terms paramount considerations. These macro challenges have forced reassessments of asset valuations and dividend sustainability across the subsector.

Interest rate dynamics further complicate the landscape. Higher rates increase the cost of capital for healthcare REITs and debt-heavy companies, while simultaneously making bonds and other fixed-income alternatives more competitive with dividend stocks. This environment rewards companies with fortress balance sheets and genuine cash generation, while pressuring those relying on capital markets access or refinancing.

Investor Implications: Risk-Adjusted Returns and Dividend Sustainability

For income-focused investors, these three stocks present a classic risk-return tradeoff. Perrigo's nearly 10% yield appears tantalizing until one examines the business fundamentals. The generic pharmaceutical environment remains brutally competitive, with pricing pressures and volume challenges creating a difficult backdrop for profitability improvement. The 23-year dividend streak carries psychological weight for management—suggesting reluctance to cut—but cannot protect shareholders if cash flows deteriorate further.

The sustainability question looms largest for Perrigo. High yields can persist in two scenarios: the company successfully stabilizes operations and margins, validating the current payout as reasonable, or the dividend eventually gets cut when cash flow reality can no longer support the distribution. Investors betting on the former scenario face execution risk; those assuming the latter face capital depreciation alongside eventual yield compression.

Healthpeak Properties presents a more constructive risk-reward profile for equity investors. The planned Janus Living spinoff offers a concrete near-term catalyst with potential to create value through separate ownership structures. Healthcare property owners with quality tenants and long-term leases have proven resilient, and Healthpeak's diversified portfolio provides some cushion against tenant concentration risk. The 7.1% yield, while elevated, appears more sustainable in this context than Perrigo's offering.

Medical Properties Trust represents a turnaround story still in early innings. After cutting its dividend significantly due to tenant bankruptcies, the company has stabilized operations and focused on debt reduction. However, the ongoing debt maturities create refinancing risk that could pressure balance sheet flexibility. For aggressive income investors comfortable with higher risk, the current 6.8% yield may compensate for this uncertainty; for conservative investors, the recent history of dividend cuts argues for caution.

Key implications for investors:

• Yield chasing without fundamentals analysis can lead to dividend cuts and capital losses
• Healthcare REITs and specialized operators face distinct risks compared to integrated pharmaceuticals
• Debt maturity schedules matter as much as current yields in assessing sustainability
• Corporate catalysts like spinoffs can unlock value beyond stated dividend yields

The Verdict: High Yields Demand High Scrutiny

These three stocks illustrate why financial markets reward patience and fundamental analysis. The highest yields often reflect the greatest uncertainty and risk. Perrigo's 9.6% yield exists because investors doubt the company can sustain it; Healthpeak's 7.1% balances reasonable fundamentals with spinoff optionality; Medical Properties Trust's 6.8% compensates for recent dividend volatility and ongoing balance sheet challenges.

For investors constructing portfolios, these stocks merit inclusion only after careful consideration of personal risk tolerance, income needs, and portfolio diversification. A ladder approach—allocating smaller positions to higher-risk, higher-yield options while maintaining core holdings in more stable dividend payers—may optimize risk-adjusted returns. The healthcare sector offers genuine value for income investors, but the sector's complexity and ongoing structural evolution demand active management and willingness to reassess positions when fundamentals deteriorate.

The coming year will test the sustainability of these yields as interest rate expectations evolve, tenant quality stabilizes or deteriorates, and operational performance clarifies management's dividend policies. Investors should monitor quarterly earnings closely, paying particular attention to cash flow generation, debt management, and management commentary on capital allocation priorities.